Condition
Cryptogenic Symptomatic Transient Ischemic Attack
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Reveal Xt Insertable Cardiac Monitor
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
Phase 4 (1)
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Reveal Xt Insertable Cardiac Monitor1
Active Sponsors
- Medtronic Cardiac Rhythm and Heart Failure1
Top Investigators
McMaster Clinic, Hamilton, Ontario, Canada
Klinik für Neurologie, Essen, Germany
Davee Department of Neurology, Chicago, IL USA
Catholic University Rome, Rome Italy
Klinikum Coburg, Germany
Related Conditions
- Cryptogenic Ischemic Stroke1